Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Multinucleated giant cells' incidence, immune markers, and significance: a study of 172 cases of papillary thyroid carcinoma.

Brooks E, Simmons-Arnold L, Naud S, Evans MF, Elhosseiny A.

Head Neck Pathol. 2009 Jun;3(2):95-9. doi: 10.1007/s12105-009-0110-9. Epub 2009 Mar 10.

PMID:
19644545
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Multinucleate giant cells in papillary thyroid carcinoma. A morphologic and immunohistochemical study.

Guiter GE, DeLellis RA.

Am J Clin Pathol. 1996 Dec;106(6):765-8.

PMID:
8980352
[PubMed - indexed for MEDLINE]
3.

Histiocytic aggregates in benign nodular goiters mimicking cytologic features of papillary thyroid carcinoma (PTC).

Nassar A, Gupta P, LiVolsi VA, Baloch Z.

Diagn Cytopathol. 2003 Nov;29(5):243-5.

PMID:
14595788
[PubMed - indexed for MEDLINE]
4.

Multinucleated giant cells in fine needle aspirates. Can they help differentiate papillary thyroid cancer from benign nodular goiter?

Tsou PL, Hsiao YL, Chang TC.

Acta Cytol. 2002 Sep-Oct;46(5):823-7.

PMID:
12365214
[PubMed - indexed for MEDLINE]
5.

Multinucleated giant cells in thyroid neoplasms. A cytologic, histologic and immunohistochemical study.

Tabbara SO, Acoury N, Sidawy MK.

Acta Cytol. 1996 Nov-Dec;40(6):1184-8.

PMID:
8960026
[PubMed - indexed for MEDLINE]
6.

Diffuse sclerosing variant of papillary thyroid carcinoma: a clinicopathologic and immunophenotypic analysis of 22 cases.

Thompson LD, Wieneke JA, Heffess CS.

Endocr Pathol. 2005 Winter;16(4):331-48.

PMID:
16627920
[PubMed - indexed for MEDLINE]
7.

Prevalence of RET/PTC expression in papillary thyroid carcinoma and its correlation with prognostic factors in a north Indian population.

Mishra A, Agrawal V, Krishnani N, Mishra SK.

J Postgrad Med. 2009 Jul-Sep;55(3):171-5. doi: 10.4103/0022-3859.57390.

PMID:
19884740
[PubMed - indexed for MEDLINE]
Free Article
8.

Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.

Pusztaszeri MP, Sadow PM, Faquin WC.

Cancer Cytopathol. 2013 Apr;121(4):206-13. doi: 10.1002/cncy.21239. Epub 2012 Oct 5.

PMID:
23042745
[PubMed - indexed for MEDLINE]
9.

Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma.

Zhu X, Sun T, Lu H, Zhou X, Lu Y, Cai X, Zhu X.

J Clin Pathol. 2010 Sep;63(9):786-9. doi: 10.1136/jcp.2010.076901. Epub 2010 Jul 19.

PMID:
20644217
[PubMed - indexed for MEDLINE]
10.

Thyroid papillary carcinoma of columnar cell type: a clinicopathologic study of 16 cases.

Wenig BM, Thompson LD, Adair CF, Shmookler B, Heffess CS.

Cancer. 1998 Feb 15;82(4):740-53.

PMID:
9477108
[PubMed - indexed for MEDLINE]
11.

Follicular adenoma with papillary architecture: a lesion mimicking papillary thyroid carcinoma.

Mai KT, Landry DC, Thomas J, Burns BF, Commons AS, Yazdi HM, Odell PF.

Histopathology. 2001 Jul;39(1):25-32.

PMID:
11454041
[PubMed - indexed for MEDLINE]
12.

Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.

Cañadas-Garre M, Becerra-Massare P, López de la Torre-Casares M, Villar-del Moral J, Céspedes-Mas S, Vílchez-Joya R, Muros-de Fuentes T, García-Calvente C, Piédrola-Maroto G, López-Nevot MA, Montes-Ramírez R, Llamas-Elvira JM.

Ann Surg. 2012 May;255(5):986-92. doi: 10.1097/SLA.0b013e31824e8d70.

PMID:
22504197
[PubMed - indexed for MEDLINE]
13.

Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.

Prasad ML, Huang Y, Pellegata NS, de la Chapelle A, Kloos RT.

Histopathology. 2004 Jul;45(1):39-46.

PMID:
15228442
[PubMed - indexed for MEDLINE]
15.

The expression and role of serum response factor in papillary carcinoma of the thyroid.

Kim HJ, Kim KR, Park HS, Jang KY, Chung MJ, Shong M, Moon WS.

Int J Oncol. 2009 Jul;35(1):49-55.

PMID:
19513551
[PubMed - indexed for MEDLINE]
16.

[Thyroglobulin levels in needle lymph node cytology for the detection of papillary thyroid cancer recurrence].

Véliz J, Brantes S, Ramos C, Aguayo J, Cáceres E, Herrera M, Barber A, Barría M, Wohllk N.

Rev Med Chil. 2008 Sep;136(9):1107-12. doi: /S0034-98872008000900003. Epub 2008 Nov 12. Spanish.

PMID:
19030653
[PubMed - indexed for MEDLINE]
Free Article
17.

Diagnostic utility of thyroglobulin detection in fine-needle aspiration of cervical cystic metastatic lymph nodes from papillary thyroid cancer with negative cytology.

Cignarelli M, Ambrosi A, Marino A, Lamacchia O, Campo M, Picca G, Giorgino F.

Thyroid. 2003 Dec;13(12):1163-7.

PMID:
14751038
[PubMed - indexed for MEDLINE]
18.

Papillary thyroid carcinoma with prominent hobnail features: a new aggressive variant of moderately differentiated papillary carcinoma. A clinicopathologic, immunohistochemical, and molecular study of eight cases.

Asioli S, Erickson LA, Sebo TJ, Zhang J, Jin L, Thompson GB, Lloyd RV.

Am J Surg Pathol. 2010 Jan;34(1):44-52. doi: 10.1097/PAS.0b013e3181c46677.

PMID:
19956062
[PubMed - indexed for MEDLINE]
19.

A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma.

Ngan ES, Lang BH, Liu T, Shum CK, So MT, Lau DK, Leon TY, Cherny SS, Tsai SY, Lo CY, Khoo US, Tam PK, Garcia-Barceló MM.

J Natl Cancer Inst. 2009 Feb 4;101(3):162-75. doi: 10.1093/jnci/djn471. Epub 2009 Jan 27.

PMID:
19176457
[PubMed - indexed for MEDLINE]
Free Article
20.

Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy.

Siraj AK, Bavi P, Abubaker J, Jehan Z, Sultana M, Al-Dayel F, Al-Nuaim A, Alzahrani A, Ahmed M, Al-Sanea O, Uddin S, Al-Kuraya KS.

J Pathol. 2007 Oct;213(2):190-9.

PMID:
17703498
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk